2-(2-Fluorophenoxy)-4-(1-methyl-1H-pyrazol-5-yl)benzamide, 98%, 5mg

2-Phenylpyrimidine, 95.0%, 5g

Naphtho[1,2-c:5,6-c']bis([1,2,5]thiadiazole)>98.0%(HPLC)200mg

Methyl 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)benzoate, 95.0%, 100mg

Carbamic acid, N-[(1R)-2-[(methylsulfonyl)oxy]-1-phenylethyl]-, 1,1-dimethylethyl ester, 98%, 500g

2-methyl-N-[(1,3,5-trimethyl-1H-pyrazol-4-yl)methyl]-1-propanamine hydrochloride, 95.0%, 5g

5-Chloro-1-iodo-2-methyl-3-nitrobenzene, 95.0%, 100mg

1-Naphthaleneacetamide, 95.0%, 1kg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-((4-methoxybenzyl)selanyl)butanoic acid, 98%, 1g

ETHYL PENT-4-YNOATE, 95.0%, 10g

4-(3-Trifluoromethyl-phenyl)-pyridine-2-carbonitrile, 95.0%, 1g

Reaktionsgefäße m. Schraubver., PP, steril, graduiert, 1,5 ml, 500 Stück

4-(Methylsulfonyl)phenylacetic acid, 97.0%, 25g